HD Clinical Ltd. has been acquired by NEXUS AG
October 2024 — NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.
HD Clinical was founded in 2005 by a group of clinicians to build an electronic clinical record system starting from departmental requirements and delivering management data derived from real-world patient information. This was a departure from the historic top-down approach of electronic patient record (EPR) systems, which were essentially upgraded patient administration systems with ‘one-size-fits-all’ clinical functionality bolted on. For 17 years, HD Clinical has been delivering digital clinical solutions to healthcare organizations around the world. The company’s solutions are used by 146 organizations across the globe, joining up healthcare organizations and hospital departments to improve the patient experience. The HD Clinical approach is designed to capture maximum engagement from clinical teams by meeting their needs and recognizing the specific requirements of each specialty. Their software and hardware are designed by their in-house team in the HD Clinical UK office.
Nexus AG provides innovative software solutions that allow users at healthcare facilities to focus on what really matters. Their goal is to offer all departments in hospitals, psychiatric wards and rehabilitation and residential institutions the best solution to the challenges they face every day.
Our role in the transaction
Oaklins S&W, one of Oaklins’ member firms in the UK, acted as lead the advisor to HD Clinical’s shareholders on the sale of the business. After winning a competitive pitch process, the team advised on all aspects of the transaction, from initial buyer research and preparation for sale to the preparation of marketing documents, leading negotiations and buyer meetings, managing due diligence and general project management throughout the deal.
Dr. Clive Layton
Founder, HD Clinical
Talk to the deal team
Related deals
Moneybox’s employee share sale has set another milestone for London’s Private Securities Market
The London Stock Exchange’s Private Securities Market (PSM) continues to demonstrate its potential as a venue for providing shareholder liquidity in high-growth private companies. Following the successful employee share sale for autonomous driving pioneer Wayve earlier this month, fintech leader Moneybox has completed a US$61 million (£45 million) employee liquidity event through the PSM. By structuring the transaction as an employee liquidity event, long-serving employees with vested equity have been able to realize some of the value they helped create while enabling Moneybox to remain private and continue its growth journey. Crowdcube managed the employee seller and investor participation process.
Learn moreLandmark US$85 million employee secondary share transaction for Wayve
Crowdcube, Europe’s largest equity crowdfunding and private market investment platform, has completed a US$85 million employee share sale for Wayve, the first employee liquidity transaction on the LSE’s Private Securities Market and the largest to date under the FCA’s PISCES framework. The deal is a milestone for UK capital markets, demonstrating how new market structures can unlock liquidity for employees and early shareholders in high-growth private companies.
Learn moreBending Spoons has completed an IPO on Nasdaq
Bending Spoons S.p.A. has completed an initial public offering (IPO) on Nasdaq, raising a total of US$1,933 million.
Learn more